(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors
Mark J. Bamford, Nicholas Bailey, Susannah Davies, David K. Dean, Leann Francis, Terence A. Panchal, Christopher A. Parr, Sanjeet Sehmi, Jon G. Steadman, Andrew K. Takle, James T. Townsend, David M. WVolume:
15
Year:
2005
Language:
english
Pages:
5
DOI:
10.1016/j.bmcl.2005.05.020
File:
PDF, 185 KB
english, 2005